Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients

World Journal of Gastroenterology

Volumn 17, Issue 10, 2011, Pages 1343-1353

  Imamura, Masayuki ^a   Komoto, Izumi ^b   Ota, Shuichi ^b   Hiratsuka, Takuya ^b   Kosugi, Shinji ^c   Doi, Ryuichiro ^c   Awane, Masaaki ^a   Inoue, Naoya ^a  

^a Kasai Electric Power Hospital   (Japan)

^b Saiseikai Noe Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Duodenopancreatic neuroendocrine tumors; Gastrinoma; Multiple endocrine neoplasia type 1; Pancreas preserving total duodenectomy; Pancreaticoduodenectomy; Selective arterial secretagogue injection test; Somatostatin receptor scintigraphy

Indexed keywords

GASTRIN; SECRETIN;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DUODENUM TUMOR; FEMALE; GASTRINOMA; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS PRESERVING TOTAL DUODENECTOMY; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; SELECTIVE ARTERIAL SECRETAGOGUE INJECTION TEST; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR SCINTISCANNING;

EID: 79955938444     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i10.1343     Document Type: Article

References (34)

1. Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreaticduodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 1998; 243: 495-500
2. Gauger PG, Thompson NW. Early surgical intervention and strategy in patients with multiple endocrine neoplasia type 1. Best Pract Res Clin Endocrinol Metab 2001; 15: 213-223
3. Wilson SD, Krzywda EA, Zhu YR, Yen TW, Wang TS, Sugg SL, Pappas SG. The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery 2008; 144: 695-701; discussion 701-702
4. Hausman MS Jr, Thompson NW, Gauger PG, Doherty GM. The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery 2004; 136: 1205-1211
5. Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, Rothmund M. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 2006; 244: 845-851; discussion 852-853
6. Tonelli F, Fratini G, Nesi G, Tommasi MS, Batignani G, Falchetti A, Brandi ML. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg 2006; 244: 61-70
7. Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg 2006; 30: 643-653
8. Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A, Proye CA. Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 2006; 30: 654-662; discussion 663-664
9. Alexander HR, Bartlett DL, Venzon DJ, Libutti SK, Doppman JL, Fraker DL, Norton JA, Gibril F, Jensen RT. Analysis of factors associated with long-term (five or more years) cure in patients undergoing operation for Zollinger-Ellison syndrome. Surgery 1998; 124: 1160-1166
10. Imamura M, Komoto I, Ota S. Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome. World J Surg 2006; 30: 1-11
11. Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M, Nies C. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 2000; 128: 958-966
12. Lairmore TC, Chen VY, DeBenedetti MK, Gillanders WE, Norton JA, Doherty GM. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 2000; 231: 909-918
13. You YN, Thompson GB, Young WF Jr, Larson D, Farley DR, Richards M, Grant CS. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery 2007; 142: 829-836; discussion 836.e1
14. Bartsch DK, Fendrich V, Langer P, Celik I, Kann PH, Rothmund M. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg 2005; 242: 757-764, discussion 764-766
15. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Imrie C, Bishop AE, Polak JM, Häcki WH, Stamm B, Heitz PU. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990; 322: 723-727
16. Imamura M, Kanda M, Takahashi K, Shimada Y, Miyahara T, Wagata T, Hashimoto M, Tobe T, Soga J. Clinicopathological characteristics of duodenal microgastrinomas. World J Surg 1992; 16: 703-709; discussion 709-710
17. Imamura M, Takahashi K, Adachi H, Minematsu S, Shimada Y, Naito M, Suzuki T, Tobe T, Azuma T. Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 1987; 205: 230-239
18. Imamura M, Takahashi K, Isobe Y, Hattori Y, Satomura K, Tobe T. Curative resection of multiple gastrinomas aided by selective arterial secretin injection test and intraoperative secretin test. Ann Surg 1989; 210: 710-718
19. Imamura M, Komoto I. Resection surgery for gastrinomas in patients with MEN 1 and ZES guided by selective arterial secretagogue injection test. World J Surg 2009; 33 Suppl 1: S67
20. Imamura M, Komoto I, Doi R, Onodera H, Kobayashi H, Kawai Y. New pancreas-preserving total duodenectomy technique. World J Surg 2005; 29: 203-207
21. Imamura M, Komoto I. Gastrinoma. In: Hubbard J, Inabnet WB, Lo C. Y. editors. Endocrine Surgery: Principles and Practice (Springer Specialist Surgery Series). London: Springer Verlag, 2009: 507-521
22. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, Vinayek R, Gardner JD, Jensen RT. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med 1989; 111: 713-722
23. Itami A, Kato M, Komoto I, Doi R, Hosotani R, Shimada Y, Imamura M. Human gastrinoma cells express calciumsensing receptor. Life Sci 2001; 70: 119-129
24. Wada M, Komoto I, Doi R, Imamura M. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. World J Surg 2002; 26: 1291-1296
25. Kato M, Imamura M, Hosotani R, Shimada Y, Doi R, Itami A, Komoto I, Kosaka MTT, Konishi J. Curative resection of microgastrinomas based on the intraoperative secretin test. World J Surg 2000; 24: 1425-1430
26. Turner JJ, Wren AM, Jackson JE, Thakker RV, Meeran K. Localization of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol (Oxf) 2002; 57: 821-825
27. Gibril F, Venzon DJ, Ojeaburu JV, Bashir S, Jensen RT. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab 2001; 86: 5282-5293
28. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Ménégaux F, Chabrier G, Borson- Chazot F, Tabarin A, Bouchard P, Delemer B, Beckers A, Bonithon-Kopp C. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 2010; 34: 249-255
29. Klöppel G, Anlauf M, Perren A. Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors. Endocr Pathol 2007; 18: 150-155
30. Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester DP, Ko CY, Bentrem DJ. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 2008; 247: 490-500
31. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB. Carcinoid tumors of the duodenum. Surgery 2005; 138: 971-977; discussion 977-978
32. Zyromski NJ, Kendrick ML, Nagorney DM, Grant CS, Donohue JH, Farnell MB, Thompson GB, Farley DR, Sarr MG. Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg 2001; 5: 588-593
33. Anlauf M, Garbrecht N, Henopp T, Schmitt A, Schlenger R, Raffel A, Krausch M, Gimm O, Eisenberger CF, Knoefel WT, Dralle H, Komminoth P, Heitz PU, Perren A, Klöppel G. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 2006; 12: 5440-5446
34. Lairmore TC, Piersall LD, DeBenedetti MK, Dilley WG, Mutch MG, Whelan AJ, Zehnbauer B. Clinic genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 2004; 239: 637-645; discussion 645-647